THE ANGIOTENSIN-TYPE-2 RECEPTORS ARE INVOLVED IN AGE-RELATED CHANGES AND NEUROINFLAMMATION IN THE SUBSTANTIA NIGRA

• Pablo Garrido-Gil,
• Ana Isabel Rodríguez Pérez,
• María A Pedrosa,
• María García-Garrote,
• Rita Valenzuela,
• Gemma Navarro-Brugal,
• Rafael Franco,
• José Luis Labandeira-García

Affiliations

Pablo Garrido-Gil

1Laboratory of Cellular and Molecular Neurobiology of Parkinson's disease, Research Center for Molecular Medicine and Chronic Diseases (CIMUS), Dept. of Morphological Sciences, IDIS, University of Santiago de Compostela, 2networking Research Center On Neurodegenerative Diseases (ciberned), Santiago de Compostela, Spain

Ana Isabel Rodríguez Pérez

1Laboratory of Cellular and Molecular Neurobiology of Parkinson's disease, Research Center for Molecular Medicine and Chronic Diseases (CIMUS), Dept. of Morphological Sciences, IDIS, University of Santiago de Compostela, 2networking Research Center On Neurodegenerative Diseases (ciberned), Santiago de Compostela, Spain

María A Pedrosa

1Laboratory of Cellular and Molecular Neurobiology of Parkinson's disease, Research Center for Molecular Medicine and Chronic Diseases (CIMUS), Dept. of Morphological Sciences, IDIS, University of Santiago de Compostela, 2networking Research Center On Neurodegenerative Diseases (ciberned), Santiago de Compostela, Spain

María García-Garrote

1Laboratory of Cellular and Molecular Neurobiology of Parkinson's disease, Research Center for Molecular Medicine and Chronic Diseases (CIMUS), Dept. of Morphological Sciences, IDIS, University of Santiago de Compostela, 2networking Research Center On Neurodegenerative Diseases (ciberned), Santiago de Compostela, Spain

Rita Valenzuela

1Laboratory of Cellular and Molecular Neurobiology of Parkinson's disease, Research Center for Molecular Medicine and Chronic Diseases (CIMUS), Dept. of Morphological Sciences, IDIS, University of Santiago de Compostela, 2networking Research Center On Neurodegenerative Diseases (ciberned), Santiago de Compostela, Spain

Gemma Navarro-Brugal

3Department of Biochemistry and Molecular Biomedicine, Universitat de Barcelona, Molecular Neurobiology Laboratory, 4networking Research Center On Neurodegenerative Diseases (ciberned), Barcelona, Spain

Rafael Franco

3Department of Biochemistry and Molecular Biomedicine, Universitat de Barcelona, Molecular Neurobiology Laboratory, 4networking Research Center On Neurodegenerative Diseases (ciberned), Barcelona, Spain

José Luis Labandeira-García

1Laboratory of Cellular and Molecular Neurobiology of Parkinson's disease, Research Center for Molecular Medicine and Chronic Diseases (CIMUS), Dept. of Morphological Sciences, IDIS, University of Santiago de Compostela, 2networking Research Center On Neurodegenerative Diseases (ciberned), Santiago de Compostela, Spain